Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cyteir Therapeutics IncCommon Stock stock | $17.29

Learn how to easily invest in Cyteir Therapeutics IncCommon Stock stock.

Cyteir Therapeutics Inc. Common Stock is a biotechnology business based in the US. Cyteir Therapeutics IncCommon Stock shares (CYT) are listed on the NASDAQ and all prices are listed in US Dollars. Cyteir Therapeutics IncCommon Stock employs 22 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cyteir Therapeutics IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CYT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cyteir Therapeutics IncCommon Stock stock price (NASDAQ: CYT)

Use our graph to track the performance of CYT stocks over time.

Cyteir Therapeutics IncCommon Stock shares at a glance

Information last updated 2021-10-10.
Latest market close$17.29
52-week range$14.00 - $23.10
50-day moving average $18.50
200-day moving average $18.66
Wall St. target price$31.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-14.90

Buy Cyteir Therapeutics IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cyteir Therapeutics IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cyteir Therapeutics IncCommon Stock price performance over time

Historical closes compared with the close of $17.29 from 2021-10-15

1 week (2021-10-08) 1.95%
1 month (2021-09-16) -16.67%
3 months (2021-07-16) -8.32%
6 months (2021-04-12) N/A
1 year (2020-10-12) N/A
2 years (2019-10-12) N/A
3 years (2018-10-12) N/A
5 years (2016-10-12) N/A

Cyteir Therapeutics IncCommon Stock financials

Gross profit TTM $-16,591,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $5.68
Market capitalisation $599.9 million

TTM: trailing 12 months

Shorting Cyteir Therapeutics IncCommon Stock shares

There are currently 1.5 million Cyteir Therapeutics IncCommon Stock shares held short by investors – that's known as Cyteir Therapeutics IncCommon Stock's "short interest". This figure is 15.4% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Cyteir Therapeutics IncCommon Stock shares can be evaluated.

Cyteir Therapeutics IncCommon Stock's "short interest ratio" (SIR)

Cyteir Therapeutics IncCommon Stock's "short interest ratio" (SIR) is the quantity of Cyteir Therapeutics IncCommon Stock shares currently shorted divided by the average quantity of Cyteir Therapeutics IncCommon Stock shares traded daily (recently around 120982.29249012). Cyteir Therapeutics IncCommon Stock's SIR currently stands at 12.65. In other words for every 100,000 Cyteir Therapeutics IncCommon Stock shares traded daily on the market, roughly 12650 shares are currently held short.

To gain some more context, you can compare Cyteir Therapeutics IncCommon Stock's short interest ratio against those of similar companies.

However Cyteir Therapeutics IncCommon Stock's short interest can also be evaluated against the total number of Cyteir Therapeutics IncCommon Stock shares, or, against the total number of tradable Cyteir Therapeutics IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cyteir Therapeutics IncCommon Stock's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Cyteir Therapeutics IncCommon Stock shares in existence, roughly 40 shares are currently held short) or 0.152% of the tradable shares (for every 100,000 tradable Cyteir Therapeutics IncCommon Stock shares, roughly 152 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Cyteir Therapeutics IncCommon Stock.

Find out more about how you can short Cyteir Therapeutics IncCommon Stock stock.

Cyteir Therapeutics IncCommon Stock share dividends

We're not expecting Cyteir Therapeutics IncCommon Stock to pay a dividend over the next 12 months.

Cyteir Therapeutics IncCommon Stock overview

Cyteir Therapeutics, Inc. operates as a clinical-stage oncology company that develops novel therapeutics based on the biology of DNA repair for the treatment of cancer and synthetic lethality therapeutics for autoimmune diseases. The company engages in manufacturing therapeutics that provide precision targeting of key DNA repair factors to induce diseased cells to self-destruct by DNA damage overload and uses an integrated drug development platform that modulates the imbalance between DNA damage and repair for the therapeutic effect to deliver a pipeline of small molecule therapeutics with a range of potential disease state applications. It provides CYT-0851, an oral small-molecule inhibitor of RAD51-mediated DNA repair. It focuses on providing treatments for a range of hematological malignancies, solid tumors, and chronic autoimmune disorders. The company was incorporated in 2012 and is based in Lexington, Massachusetts. .

Frequently asked questions

What percentage of Cyteir Therapeutics IncCommon Stock is owned by insiders or institutions?
Currently 4.273% of Cyteir Therapeutics IncCommon Stock shares are held by insiders and 48.112% by institutions.
How many people work for Cyteir Therapeutics IncCommon Stock?
Latest data suggests 22 work at Cyteir Therapeutics IncCommon Stock.
When does the fiscal year end for Cyteir Therapeutics IncCommon Stock?
Cyteir Therapeutics IncCommon Stock's fiscal year ends in December.
Where is Cyteir Therapeutics IncCommon Stock based?
Cyteir Therapeutics IncCommon Stock's address is: 128 Spring Street, Lexington, MA, United States, 02421
What is Cyteir Therapeutics IncCommon Stock's ISIN number?
Cyteir Therapeutics IncCommon Stock's international securities identification number is: US23284P1030

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site